Artificial intelligence-based prostate cancer risk stratification via large-scale ultrasound images paired with histopathology
Background Prostate cancer (PCa) is primarily screened and diagnosed via prostate-specific antigen (PSA) testing, digital rectal examination (DRE), multiparametric magnetic resonance imaging (mpMRI), and transrectal ultrasound (TRUS). Nevertheless, an open research challenge remains to develop artificial intelligence (...